Swiss researchers may have discovered the reason drug-eluting stents cause thrombosis, and their study results are ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
The FDA has granted 510(k) marketing clearance for Atrium Medical Corp.’s ClearWay RX, a therapeutic perfusion catheter ...
The latest in thrombus removal devices from Possis has received FDA clearance — the new AngioJet Ultra ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
UnitedHealthcare has announced its support for the “Door to Balloon (D2B): An Alliance for Quality” campaign ...
In a new, five-year agreement signed last week, Datascope’s InterVascular Division will become the distributor of Sorin ...
The embolic protection system Boston Scientific Corp. originally designed for coronary saphenous vein graft ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Diagnostic & Invasive Cardiology editor Kim Phelan spoke with Jeff Mirviss, vice president of Stent Marketing at Boston ...
A new study, released today by the Society for Cardiovascular Angiography and Interventions, shows that the ...
Possis Medical, Inc. has closed a $2.5 million equity investment in Rafael Medical Technologies, Inc., which gives ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
Volcano Corp., Stanford University, Cardialysis and the Cardiovascular Research Foundation in which Volcano will provide ...
The FDA panel that convened for an intense, two-day review of drug-eluting stents last week heard key testimony from ...
The FDA panel that is re-evaluating the safety of drug-eluting stents convenes Dec. 7 and 8 at the Hilton Washington DC ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
The FDA will revisit a device tomorrow that it cleared for U.S. sale three years ago — drug-eluting stents will be the ...
Recent downplay of the media’s attention to DES-related thrombosis during both the TCT and AHA conferences this fall may ...
Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...